
Novogene Global
Introducing Shallow Shotgun Metagenomic Sequencing.
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
Total Funding | 000k |
Novogene is a global leader in genomic services and solutions, specializing in next-generation sequencing (NGS) technologies. The company serves a diverse range of clients including academic institutions, healthcare providers, and pharmaceutical companies. Operating in the genomics market, Novogene leverages state-of-the-art platforms like the Falcon and Chromium systems to deliver highly efficient, reliable, and flexible sequencing services. The business model is centered around providing comprehensive genomic analysis and sequencing services, which generate revenue through service fees and long-term contracts. Novogene's innovative approach includes the deployment of fully automated, intelligent delivery systems and the establishment of advanced lab facilities, such as the new single-cell lab in Silicon Valley. The company's vision is to advance genomics to improve life, positioning itself as a key player in the global genomics industry.
Keywords: Genomic Sequencing, NGS, Automation, Intelligent Delivery, Falcon System, Chromium Platform, Healthcare, Pharmaceutical, Genomic Analysis, Silicon Valley Lab.